Subcutaneous immunoglobulin replacement therapy: the European experience.
PURPOSE OF REVIEW: Rapid subcutaneous immunoglobulin (SCIg) infusions have been used as an important method of delivering replacement immunoglobulin (Ig) to patients with primary immune deficiencies (PIDs) in Europe over the last 25 years. This review provides a comprehensive interpretation of the l...
Main Authors: | , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|